Even for the most experienced sites, starting up a new study is notoriously inefficient and burdensome. With protocols and regulations growing in complexity, it’s harder to recruit and retain patients, and setting up all the technology their expected to use takes a valiant effort. Many sites become so overwhelmed by the administrative burden that they withdraw after a single trial, further reducing the pool of investigators available for study opportunities from sponsors.